Your session is about to expire
← Back to Search
Integrative Smoking Cessation for HIV Patients
Study Summary
This trial will test if a combined smoking cessation intervention that uses rewards and mindfulness training is more effective than other interventions in helping HIV patients quit smoking.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are willing to try to quit smoking within the next month.You are pregnant.You have smoked at least 5 cigarettes per day during the last year.You are currently undergoing treatment to quit smoking, stop alcoholism, or recover from drug addiction.You are under 18 years old.You are currently receiving treatment for a mental health condition.
- Group 1: MT plus NRT with additional CM Group
- Group 2: CM plus NRT Group
- Group 3: CM plus NRT with additional MT Group
- Group 4: MT plus NRT Group
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the cap on participants in this clinical trial?
"Affirmative. Clinicaltrials.gov records demonstrate that this clinical trial, initially advertised on April 1st 2022, is still seeking participants. The research project needs to recruit 75 individuals from one medical site."
What prior experiments have tested the effectiveness of Contingency Management Smoking Cessation Intervention?
"There are presently 71 trials looking into the efficacy of Contingency Management Smoking cessation Intervention, with 5 studies currently in Phase 3. Most research is taking place in Green Bay, Wisconsin; however, 204 medical centres across the globe are also running their own independent investigations."
What risks could a patient potentially face when using Contingency Management Smoking Cessation Intervention?
"There is ample clinical documentation of CM-SCI's safety, so it was rated a 3."
Is it currently possible for individuals to partake in this medical experiment?
"Yes, the information accessible on clinicaltrials.gov attests to this research study's active recruitment period. It was originally posted on April 1st 2022 and is looking for 75 participants from a single site with an update having been made yesterday (August 30th)."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
How responsive is this trial?
Typically responds via
Most responsive sites:
- University of Miami: < 48 hours
Average response time
- < 2 Days
Share this study with friends
Copy Link
Messenger